Triethylamine → 3,5-difluoro-N-(4-methyl-1,2,5-oxadiazol-3-yl)isonicotinamide
Reaction equation
[F:1][C:2]1[CH:10]=[N:9][CH:8]=[C:7]([F:11])[C:3]=1[C:4]([OH:6])=O.[CH3:12][C:13]1[C:14]([NH2:18])=[N:15][O:16][N:17]=1.C(N(CC)CC)C.C(P1(=O)OP(=O)(CCC)OP(=O)(CCC)O1)CC>ClCCl.CN(C1C=CN=CC=1)C>[F:11][C:7]1[CH:8]=[N:9][CH:10]=[C:2]([F:1])[C:3]=1[C:4]([NH:18][C:14]1[C:13]([CH3:12])=[N:17][O:16][N:15]=1)=[O:6]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
200 mg (1.26 mmol) of 3,5-difluoroisonicotinic acid and 125 mg (1.26 mmol) of 4-methyl-1,2,5-oxadiazol-3-amine are dissolved at RT in 6 ml of dichloromethane, and 0.88 ml (6.29 mmol) of triethylamine, 31 mg (0.25 mmol) of DMAP and 1.20 g (1.89 mmol) of 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (50% solution in THF) are added. The reaction mixture is stirred at RT for 20 h and then washed twice with 5 ml each time of water. The organic phase is dried over Na2SO4 and concentrated. The residue is purified by column chromatography (silica gel, heptane/ethyl acetate). Yield: 100 mg (31%).
Workup
- washwashed twice with 5 ml each time of water
- dry with materialThe organic phase is dried over Na2SO4
- concentrationconcentrated
- customThe residue is purified by column chromatography (silica gel, heptane/ethyl acetate)
Sources & evidence
- ORD record
- ord-2396fe2f89d441e0bf309779eb2ca148
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09035064B2
Reaction notes
Loading…